Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	lipopolysaccharide binding	HSPD1 ADGRB1 TLR4 LTF	1.31e-04	48	108	4	GO:0001530
GeneOntologyMolecularFunction	pancreatic polypeptide receptor activity	NPY4R2 NPY4R	1.73e-04	4	108	2	GO:0001602
GeneOntologyMolecularFunction	protein-hormone receptor activity	TSHR LEPR LHCGR	2.20e-04	22	108	3	GO:0016500
GeneOntologyMolecularFunction	peptide hormone binding	IDE LEPR LHCGR NPY4R	2.23e-04	55	108	4	GO:0017046
MousePheno	abnormal vascular smooth muscle physiology	LEPR PTK2B ADRA1A GUCY1A1 KCNMB1 MMP2 MMP9	1.91e-05	140	83	7	MP:0005595
Domain	NPY4_rcpt	NPY4R2 NPY4R	3.56e-05	2	112	2	IPR001933
Pubmed	Role of matrix metalloproteinases 2 and 9, toll-like receptor 4 and platelet-leukocyte aggregate formation in sepsis-associated thrombocytopenia.	TLR4 MMP2 MMP9	3.25e-08	3	112	3	29734352
Pubmed	E3 ubiquitin ligase RNF123 targets lamin B1 and lamin-binding proteins.	HSPD1 CARM1 ATRN MYH3 LAMB4 ZNF618 ADGRB1 GPAM ZZEF1 ADRA1A MROH8 BTD MMP2	7.64e-07	736	112	13	29676528
Pubmed	Nef and cell signaling transduction: a possible involvement in the pathogenesis of human immunodeficiency virus-associated dementia.	CCL5 MMP2 MMP9	1.80e-06	8	112	3	19455469
Pubmed	Curcumin induces apoptosis and suppresses invasion through MAPK and MMP signaling in human monocytic leukemia SHI-1 cells.	MMP2 MMP9	1.03e-05	2	112	2	26134921
Pubmed	Association between the polymorphisms in MMP-2 and MMP-9 with adiposity and mammographic features.	MMP2 MMP9	1.03e-05	2	112	2	32394348
Pubmed	Matrix metalloproteinase-9 facilitates glial scar formation in the injured spinal cord.	MMP2 MMP9	1.03e-05	2	112	2	19074020
Pubmed	Increased restenosis rate after implantation of drug-eluting stents in patients with elevated serum activity of matrix metalloproteinase-2 and -9.	MMP2 MMP9	1.03e-05	2	112	2	20129576
Pubmed	Increased activity and expression of gelatinases in ischemic colitis.	MMP2 MMP9	1.03e-05	2	112	2	17089188
Pubmed	MMP-2/MMP-9 plasma level and brain expression in cerebral amyloid angiopathy-associated hemorrhagic stroke.	MMP2 MMP9	1.03e-05	2	112	2	21707819
Pubmed	Cutting edge: heat shock protein 60 is a putative endogenous ligand of the toll-like receptor-4 complex.	HSPD1 TLR4	1.03e-05	2	112	2	10623794
Pubmed	Comparison of the prognostic value of matrix metalloproteinases 2 and 9 in cutaneous melanoma.	MMP2 MMP9	1.03e-05	2	112	2	18187184
Pubmed	Study on the expression of Toll-like receptor 4 and matrix metalloproteinase-9 in patients with chronic obstructive pulmonary disease and their clinical significance.	TLR4 MMP9	1.03e-05	2	112	2	28537664
Pubmed	Interactions of central obesity with rs3918242 on risk of non-alcoholic fat liver disease: a preliminary case-control study.	MMP2 MMP9	1.03e-05	2	112	2	26097608
Pubmed	Emodin, aloe-emodin and rhein inhibit migration and invasion in human tongue cancer SCC-4 cells through the inhibition of gene expression of matrix metalloproteinase-9.	MMP2 MMP9	1.03e-05	2	112	2	20372784
Pubmed	Role of gelatinases in disuse-induced skeletal muscle atrophy.	MMP2 MMP9	1.03e-05	2	112	2	19790245
Pubmed	Collagenase expression and activity is modulated by the interaction of collagen types, hypoxia, and nutrition in human lung cells.	MMP2 MMP9	1.03e-05	2	112	2	15672417
Pubmed	Disruption of CADM1-dependent cell-cell adhesion in human oral squamous cell carcinoma cells results in tumor progression, possibly through an increase of MMP-2 and MMP-9 expression.	MMP2 MMP9	1.03e-05	2	112	2	38030062
Pubmed	Matrix metalloproteinase variants associated with risk and clinical outcome of esophageal cancer.	MMP2 MMP9	1.03e-05	2	112	2	25966235
Pubmed	Growth factor-enhanced expression and activity of matrix metalloproteases in human non-small cell lung cancer cell lines.	MMP2 MMP9	1.03e-05	2	112	2	14981939
Pubmed	The influence of opioids on matrix metalloproteinase-2 and -9 secretion and mRNA levels in MCF-7 breast cancer cell line.	MMP2 MMP9	1.03e-05	2	112	2	20563853
Pubmed	Modulation of MMP-2 and -9 secretion by cytokines, inducers and inhibitors in human melanoma A-2058 cells.	MMP2 MMP9	1.03e-05	2	112	2	28440509
Pubmed	Inhibitory effects of tetrandrine on epidermal growth factor-induced invasion and migration in HT29 human colorectal adenocarcinoma cells.	MMP2 MMP9	1.03e-05	2	112	2	26648313
Pubmed	Suppression of MMP-9 activity by NDRG2 expression inhibits clear cell renal cell carcinoma invasion.	NDRG2 MMP9	1.03e-05	2	112	2	22692967
Pubmed	Clinical significance of matrix metalloproteinase 2 and 9 in breast cancer.	MMP2 MMP9	1.03e-05	2	112	2	19574670
Pubmed	Inhibition of MMP-2 and MMP-9 attenuates surgery-induced cognitive impairment in aged mice.	MMP2 MMP9	1.03e-05	2	112	2	37939860
Pubmed	Expression of Matrix Metalloproteinases-2/-9 is Associated With Microvessel Density in Pancreatic Cancer.	MMP2 MMP9	1.03e-05	2	112	2	26866436
Pubmed	Congenital Muscular Dystrophy 1D Causes Matrix Metalloproteinase Activation And Blood-Brain Barrier Impairment.	MMP2 MMP9	1.03e-05	2	112	2	27915985
Pubmed	The role of MMP-2 and MMP-9 polymorphisms in sporadic intracranial aneurysms.	MMP2 MMP9	1.03e-05	2	112	2	16961137
Pubmed	Prognostic values of tumoral MMP2 and MMP9 overexpression in breast cancer: a systematic review and meta-analysis.	MMP2 MMP9	1.03e-05	2	112	2	33568081
Pubmed	Novel molecular imaging ligands targeting matrix metalloproteinases 2 and 9 for imaging of unstable atherosclerotic plaques.	MMP2 MMP9	1.03e-05	2	112	2	29190653
Pubmed	Matrix metalloproteinase-2 and -9 activities in human keloids, hypertrophic and atrophic scars: a pilot study.	MMP2 MMP9	1.03e-05	2	112	2	19165813
Pubmed	Increased cerebral matrix metalloprotease-9 activity is associated with compromised recovery in the diabetic db/db mouse following a stroke.	LEPR MMP9	1.03e-05	2	112	2	21923664
Pubmed	MMP-2 and MMP-9 as prognostic markers for the early detection of urinary bladder cancer.	MMP2 MMP9	1.03e-05	2	112	2	30548095
Pubmed	Inhibition of MMP-2 and MMP-9 decreases cellular migration, and angiogenesis in in vitro models of retinoblastoma.	MMP2 MMP9	1.03e-05	2	112	2	28633655
Pubmed	Matrix metalloproteinase expression and activity in trophoblast-decidual tissues at organogenesis in CF-1 mouse.	MMP2 MMP9	1.03e-05	2	112	2	22714107
Pubmed	Linking neuron and skin: matrix metalloproteinases in amyotrophic lateral sclerosis (ALS).	MMP2 MMP9	1.03e-05	2	112	2	19523650
Pubmed	Blockade of MMP-2 and MMP-9 inhibits corneal lymphangiogenesis.	MMP2 MMP9	1.03e-05	2	112	2	28669039
Pubmed	Expression of matrix metalloproteinases 2 and 9 in human trophoblasts of normal and preeclamptic placentas: preliminary findings.	MMP2 MMP9	1.03e-05	2	112	2	19716817
Pubmed	Red Grape Skin Polyphenols Blunt Matrix Metalloproteinase-2 and -9 Activity and Expression in Cell Models of Vascular Inflammation: Protective Role in Degenerative and Inflammatory Diseases.	MMP2 MMP9	1.03e-05	2	112	2	27589705
Pubmed	Induction of secreted matrix metalloproteinase-9 activity in human melanoma cells by extracellular matrix proteins and cytokines.	MMP2 MMP9	1.03e-05	2	112	2	16718267
Pubmed	Role of matrix metalloproteinases in delayed neuronal damage after transient global cerebral ischemia.	MMP2 MMP9	1.03e-05	2	112	2	14736853
Pubmed	[Inhibitory effect of curcumin on MMP-2 and MMP-9 expression induced by polyethylene wear particles and its mechanism].	MMP2 MMP9	1.03e-05	2	112	2	19594013
Pubmed	Letrozole as a potent inhibitor of cell proliferation and expression of metalloproteinases (MMP-2 and MMP-9) by human epithelial breast cancer cells.	MMP2 MMP9	1.03e-05	2	112	2	12569569
Pubmed	Expression of metalloproteinases (MMP-2 and MMP-9) in basal-cell carcinoma.	MMP2 MMP9	1.03e-05	2	112	2	27406386
Pubmed	A critical role for matrix metalloproteinases in liver regeneration.	MMP2 MMP9	1.03e-05	2	112	2	18222481
Pubmed	Serum levels of matrix metalloproteinase 2 and matrix metalloproteinase 9 elevated in polypoidal choroidal vasculopathy but not in age-related macular degeneration.	MMP2 MMP9	1.03e-05	2	112	2	23559867
Pubmed	Modulation of MMP-2 and MMP-9 by cytokines, mitogens and inhibitors in lung cancer and malignant mesothelioma cell lines.	MMP2 MMP9	1.03e-05	2	112	2	19885578
Pubmed	Matrix metalloproteinases 2 and 9 are elevated in human preterm laboring uterine myometrium and exacerbate uterine contractility†.	MMP2 MMP9	1.03e-05	2	112	2	30951583
Pubmed	Matrix metalloproteinase activity correlates with blastema formation in the regenerating MRL mouse ear hole model.	MMP2 MMP9	1.03e-05	2	112	2	12557216
Pubmed	Heavy smoking before coronary surgical procedures affects the native matrix metalloproteinase-2 and matrix metalloproteinase-9 gene expression in saphenous vein conduits.	MMP2 MMP9	1.03e-05	2	112	2	23146278
Pubmed	[Type IV collagenases (MMP-2 and MMP-9) and their substrates--intracellular proteins, hormones, cytokines, chemokines and their receptors].	MMP2 MMP9	1.03e-05	2	112	2	17718386
Pubmed	Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines.	MMP2 MMP9	1.03e-05	2	112	2	15059974
Pubmed	The involvement of MMP-2 and MMP-9 in heart exercise-related angiogenesis.	MMP2 MMP9	1.03e-05	2	112	2	24195673
Pubmed	Matrix metalloproteinase-2 and -9 in the urine of prostate cancer patients.	MMP2 MMP9	1.03e-05	2	112	2	20514437
Pubmed	Anti-invasive activity of diallyl disulfide through tightening of tight junctions and inhibition of matrix metalloproteinase activities in LNCaP prostate cancer cells.	MMP2 MMP9	1.03e-05	2	112	2	20600798
Pubmed	[Inhibitory effects of soluble endoglin on invasive ability of cultured cytotrophoblasts of first trimester of pregnancy].	MMP2 MMP9	1.03e-05	2	112	2	21681346
Pubmed	Expression of matrix metalloproteinases 2 and 9 in human gastric cancer and superficial gastritis.	MMP2 MMP9	1.03e-05	2	112	2	20333791
Pubmed	Evaluation of metalloproteinase 2 and 9 levels and their inhibitors in diabetic and healthy subjects.	MMP2 MMP9	1.03e-05	2	112	2	17320450
Pubmed	Mere15, a novel polypeptide from Meretrix meretrix, inhibits adhesion, migration and invasion of human lung cancer A549 cells via down-regulating MMPs.	MMP2 MMP9	1.03e-05	2	112	2	23134156
Pubmed	Matrix metalloproteinase and heparin-stimulated serine proteinase activities in post-prostate massage urine of men with prostate cancer.	MMP2 MMP9	1.03e-05	2	112	2	29175302
Pubmed	Detection and monitoring of localized matrix metalloproteinase upregulation in a murine model of asthma.	MMP2 MMP9	1.03e-05	2	112	2	24508733
Pubmed	Activities of cardiac tissue matrix metalloproteinases 2 and 9 are reduced by remote ischemic preconditioning in cardiosurgical patients with cardiopulmonary bypass.	MMP2 MMP9	1.03e-05	2	112	2	24712447
Pubmed	Ratio of matrix metalloproteinase-2 to -9 is a more accurate predictive biomarker in women with suspected pre-eclampsia.	MMP2 MMP9	1.03e-05	2	112	2	28143958
Pubmed	[The correlation between polymorphisms of matrix metalloproteinase-2 and -9 genes and colorectal cancer of Chinese patients].	MMP2 MMP9	1.03e-05	2	112	2	16456793
Pubmed	On the structure and chromosome location of the 72- and 92-kDa human type IV collagenase genes.	MMP2 MMP9	1.03e-05	2	112	2	1851724
Pubmed	The expression and activity of MMPs are increased in residual tumor tissues after the termination of immunotherapy.	MMP2 MMP9	1.03e-05	2	112	2	18704294
Pubmed	MMP-2 together with MMP-9 overexpression correlated with lymph node metastasis and poor prognosis in early gastric carcinoma.	MMP2 MMP9	1.03e-05	2	112	2	28621235
Pubmed	Inhibition of MMP2/MMP9 after spinal cord trauma reduces apoptosis.	MMP2 MMP9	1.03e-05	2	112	2	18670324
Pubmed	Cytokine Response to Diet and Exercise Affects Atheromatous Matrix Metalloproteinase-2/9 Activity in Mice.	MMP2 MMP9	1.03e-05	2	112	2	28883215
Pubmed	A vicious cycle involving release of heat shock protein 60 from injured cells and activation of toll-like receptor 4 mediates neurodegeneration in the CNS.	HSPD1 TLR4	1.03e-05	2	112	2	18322079
Pubmed	Correlations of MMP-2 and MMP-9 gene polymorphisms with the risk of hepatopulmonary syndrome in cirrhotic patients: A case-control study.	MMP2 MMP9	1.03e-05	2	112	2	30392570
Pubmed	Finasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulation.	MMP2 MMP9	1.03e-05	2	112	2	24386413
Pubmed	Increased production of matrix metalloproteinases in Helicobacter pylori-associated human gastritis.	MMP2 MMP9	1.03e-05	2	112	2	15165255
Pubmed	MMP-2 and MMP-9 in normal mucosa are independently associated with outcome of colorectal cancer patients.	MMP2 MMP9	1.03e-05	2	112	2	22472880
Pubmed	Prognostic significance of expression of matrix metalloproteinase in colorectal adenocarcinomas and their metastases.	MMP2 MMP9	1.03e-05	2	112	2	18214299
Pubmed	Genetic variations and plasma levels of gelatinase A (matrix metalloproteinase-2) and gelatinase B (matrix metalloproteinase-9) in proliferative diabetic retinopathy.	MMP2 MMP9	1.03e-05	2	112	2	18552985
Pubmed	Amsacrine suppresses matrix metalloproteinase-2 (MMP-2)/MMP-9 expression in human leukemia cells.	MMP2 MMP9	1.03e-05	2	112	2	24122234
Pubmed	The effect of substance P and its specific antagonist (aprepitant) on the expression of MMP-2, MMP-9, VEGF, and VEGFR in ovarian cancer cells.	MMP2 MMP9	1.03e-05	2	112	2	35960409
Pubmed	Isolation and expression of Napor/CUG-BP2 in embryo development.	CELF1 CELF2	1.03e-05	2	112	2	12763013
Pubmed	Gelatinases (MMP-2 and MMP-9) are preferentially expressed by Th1 vs. Th2 cells.	MMP2 MMP9	1.03e-05	2	112	2	15885317
Pubmed	Changes in activities of circulating MMP-2 and MMP-9 in patients suffering from heart failure in relation to gender, hypertension and treatment: a cross-sectional study.	MMP2 MMP9	1.03e-05	2	112	2	27643937
Pubmed	Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases.	MMP2 MMP9	1.03e-05	2	112	2	22421441
Pubmed	Elevated Expression of Matrix Metalloproteinase-9 not Matrix Metalloproteinase-2 Contributes to Progression of Extracranial Arteriovenous Malformation.	MMP2 MMP9	1.03e-05	2	112	2	27075045
Pubmed	Expression of a dominant negative CELF protein in vivo leads to altered muscle organization, fiber size, and subtype.	CELF1 CELF2	1.03e-05	2	112	2	21541285
Pubmed	Heat shock protein 60 overexpression is associated with the progression and prognosis in gastric cancer.	HSPD1 MMP9	1.03e-05	2	112	2	25207654
Pubmed	Interethnic differences in the distribution of matrix metalloproteinases genetic polymorphisms are consistent with interethnic differences in disease prevalence.	MMP2 MMP9	1.03e-05	2	112	2	20590473
Pubmed	The integrin cytoplasmic-tail motif EKQKVDLSTDC is sufficient to promote tumor cell invasion mediated by matrix metalloproteinase (MMP)-2 or MMP-9.	MMP2 MMP9	1.03e-05	2	112	2	15067014
Pubmed	Relationship between expression of matrix metalloproteinase-2 and matrix metalloproteinase-9 and invasion ability of cervical cancer cells.	MMP2 MMP9	1.03e-05	2	112	2	11956628
Pubmed	Differential vesicular distribution and trafficking of MMP-2, MMP-9, and their inhibitors in astrocytes.	MMP2 MMP9	1.03e-05	2	112	2	19780201
Pubmed	[Expression and significance of matrix metalloproteinase and tissue inhibitor of metalloproteinase in nasal cavity squamous cell carcinoma].	MMP2 MMP9	1.03e-05	2	112	2	21624249
Pubmed	Heterogeneity of serum gelatinases MMP-2 and MMP-9 isoforms and charge variants.	MMP2 MMP9	1.03e-05	2	112	2	24616914
Pubmed	Matrix metalloproteinases-2 (MMP-2) and matrix metalloproteinases -9 (MMP-9) are differentially expressed in different regions of normal and preeclampsia placentae.	MMP2 MMP9	1.03e-05	2	112	2	29665148
Pubmed	Association of MMP-2 and MMP-9 Polymorphisms with Diabetes and Pathogenesis of Diabetic Complications.	MMP2 MMP9	1.03e-05	2	112	2	36142480
Pubmed	Evaluation of the expression of metalloproteinases 2 and 9 and their tissue inhibitors in colon cancer cells treated with phytic acid.	MMP2 MMP9	1.03e-05	2	112	2	21229878
Pubmed	Ganoderic acid Me inhibits tumor invasion through down-regulating matrix metalloproteinases 2/9 gene expression.	MMP2 MMP9	1.03e-05	2	112	2	18946196
Pubmed	Increased activities of cardiac matrix metalloproteinases matrix metalloproteinase (MMP)-2 and MMP-9 are associated with mortality during the acute phase of experimental Trypanosoma cruzi infection.	MMP2 MMP9	1.03e-05	2	112	2	18444803
Pubmed	Matrix Metalloproteinase 2 and 9 Enzymatic Activities are Selectively Increased in the Myocardium of Chronic Chagas Disease Cardiomyopathy Patients: Role of TIMPs.	MMP2 MMP9	1.03e-05	2	112	2	35372112
Pubmed	Role of matrix metalloproteinases 2 and 9 in ex vivo Trypanosoma cruzi infection of human placental chorionic villi.	MMP2 MMP9	1.03e-05	2	112	2	23107342
Pubmed	Matrix metalloproteinases 2 and 9, and extracellular matrix in Kaposi's sarcoma.	MMP2 MMP9	1.03e-05	2	112	2	20482566
Pubmed	MMP2 and MMP9 contribute to lung ischemia-reperfusion injury via promoting pyroptosis in mice.	MMP2 MMP9	1.03e-05	2	112	2	35705936
GeneFamily	Glycoprotein hormone receptors	TSHR LHCGR	5.50e-05	3	78	2	199
GeneFamily	WD repeat domain containing\|BEACH domain containing	NBEAL1 WDFY4	6.49e-04	9	78	2	1230
GeneFamily	Maestro heat like repeat containing	MROH5 MROH8	9.85e-04	11	78	2	636
CoexpressionAtlas	Stem Cells, SC.LTSL.BM, CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Bone marrow, avg-1	CLEC5A ZNF521 LHCGR GUCY1A1 TLR4 CC2D2A PAM LTF MMP9 TOP2A SORD	8.38e-06	409	109	11	GSM476663_500
ToppCell	368C-Lymphocytic-CD8+_Cytotoxic_T-cell\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	GPAM IDE CEMIP LRFN2 TLR4 CCL5 KLRD1	9.81e-08	148	112	7	e7bbb5ddf44b11b8495e83863fbf1fd9f3f24472
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P3\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	RBPJL ADGB WDR93 CCL5 LTF MMP2	1.02e-07	89	112	6	9e7041ab9409028007fefe53db6d1048eafae93b
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)-\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	RBPJL ADGB WDR93 CCL5 LTF MMP2	1.02e-07	89	112	6	436e1229ee28517c11dfe0a5d1cdad3477419e00
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	RBPJL ADGB WDR93 CCL5 LTF MMP2	1.02e-07	89	112	6	e7abf4af18d63c9384d25365a827e85a9adee964
ToppCell	Posterior_cortex-Macroglia-POLYDENDROCYTE-P3-Tnr-Polydendrocyte.Tnr.Cspg5_(Cspg5)\|Posterior_cortex / BrainAtlas - Mouse McCarroll V32	RBPJL ADGB WDR93 CCL5 LTF MMP2	1.02e-07	89	112	6	4e5f4c0404968422703c248488e6b2ee8737dc00
ToppCell	COVID-19-kidney-Macrophages\|COVID-19 / Disease (COVID-19 only), tissue and cell type	HSPD1 BMP2K CLEC5A WDFY4 DENND1A PTK2B MMP9	6.81e-07	197	112	7	3912301018d0863144dcfac8d1fa8adc081748d7
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocye.Tnr.Bmp4_(Bmp4)-\|Striatum / BrainAtlas - Mouse McCarroll V32	RBPJL ESM1 DCT CCL5 MMP2	3.81e-06	93	112	5	ea380272fdcb29c5d77bd9bad33d4c622a263db9
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P2-Tnr\|Striatum / BrainAtlas - Mouse McCarroll V32	RBPJL ESM1 DCT CCL5 MMP2	3.81e-06	93	112	5	a444550ec6e6c580ec23b43737187f94a2565585
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P2-Tnr-Polydendrocye.Tnr.Bmp4_(Bmp4)\|Striatum / BrainAtlas - Mouse McCarroll V32	RBPJL ESM1 DCT CCL5 MMP2	3.81e-06	93	112	5	7b41af7494d78e94b5e7c9728b287833e8673fa4
ToppCell	Striatum-Macroglia-POLYDENDROCYTE-P2\|Striatum / BrainAtlas - Mouse McCarroll V32	RBPJL ESM1 DCT CCL5 MMP2	3.81e-06	93	112	5	d6a11279657854425ecb1350b9802d9eaad7b24a
ToppCell	TCGA-Brain-Primary_Tumor-Low_Grade_Glioma-Astrocytoma-9\|TCGA-Brain / Sample_Type by Project: Shred V9	SLC25A33 GPAM NDRG2 TLR4 ACSM5 SORD	4.13e-06	167	112	6	013971700e80b71e4b8c79b8fff0d8beeac295c3
ToppCell	3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-\|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	SFRP2 TECTA OVCH1 ABCA10 LEPR MMP2	4.89e-06	172	112	6	e37c0b5b547a7345179ab258dd2141fec7064c17
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-luminal_bladder_epithelial_cell_(umbrella_cell)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL ATRN SPINT1 NDRG2 IGF2BP1 PSAPL1	7.20e-06	184	112	6	382b1e90b3f437af596750669c0465a169d97095
ToppCell	TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Mature_Teratoma\|TCGA-Testes / Sample_Type by Project: Shred V9	DCT NPY4R2 ADRA1A KCNMB1 C1QTNF5	7.25e-06	106	112	5	ed950bbb10059439b4b95b6e67a0d4de02e161bd
ToppCell	TCGA-Testes-Primary_Tumor-Testicular_Germ_Cell_Tumor-Non-Seminoma-_Mature_Teratoma-4\|TCGA-Testes / Sample_Type by Project: Shred V9	DCT NPY4R2 ADRA1A KCNMB1 C1QTNF5	7.25e-06	106	112	5	945b9878b0ca49cbd795a8ca3954d0398c9fadb6
ToppCell	facs-Trachea-18m-Mesenchymal-fibroblast-fibroblast_of_trachea-\|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	MYH3 TECTA HOXC11 SEMA6D MEIOC NPAS4	7.66e-06	186	112	6	bdc87e4631a8ea73e262e541aa84a28f24c94b00
ToppCell	droplet-Tongue-nan-24m-Epithelial-parabasal\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 IDE NDRG2 CEMIP PSAPL1 GOLGA7B	7.66e-06	186	112	6	18c06041c6c8a0ebac17b3c8aaebd67e652d315a
ToppCell	droplet-Bladder-BLADDER-1m-Epithelial-bladder_urothelial_cell\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL ATRN SPINT1 NDRG2 IGF2BP1 PSAPL1	7.90e-06	187	112	6	aa336fb568a24e12c0454265ddd71ed10a6614cf
ToppCell	E18.5-samps-Mesenchymal\|E18.5-samps / Age Group, Lineage, Cell class and subclass	ETV1 NDRG2 HHIP CELF2 GUCY1A1 MMP2	8.39e-06	189	112	6	0c18d3de4720759cf802eefb4d0ddde2a9246a1a
ToppCell	droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell-neuroendocrine\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LHCGR ADRA1A LRFN2 SEMA6D GUCY1A1 KCNMB1	8.91e-06	191	112	6	72f1ddc09080dbfea8d51294cbf7f9d4925f9cc0
ToppCell	droplet-Trachea-3m-Epithelial-airway_epithelial-neuroendocrine_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	LHCGR ADRA1A LRFN2 SEMA6D GUCY1A1 KCNMB1	8.91e-06	191	112	6	6e7f589efc997f32175e0789c5ea7ca46e1389b8
ToppCell	droplet-Trachea-nan-3m-Epithelial-neuroendocrine_cell\|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	LHCGR ADRA1A LRFN2 SEMA6D GUCY1A1 KCNMB1	8.91e-06	191	112	6	3ce403e0beedb544edeb3ae6eb30267040d00c21
ToppCell	Monocytes-Tissue-resident_macrophages\|Monocytes / Immune cells in Kidney/Urine in Lupus Nephritis	BMP2K ZNF618 CLEC5A NDRG2 KCNMB1 MMP2	9.46e-06	193	112	6	198552810dcac8d0ca63a78badd6702b49ff6edf
ToppCell	E15.5-Mesenchymal\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SFRP2 ETV1 HHIP CELF2 GUCY1A1 MMP2	9.46e-06	193	112	6	22a9f5b61f197757f72840b9cb849cdb20430e72
ToppCell	E17.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SFRP2 ETV1 NDRG2 HHIP CELF2 MMP2	1.00e-05	195	112	6	1daddd801bd4596fffbdb822fc326d5127c96004
ToppCell	E17.5-Mesenchymal-myocytic_cell\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SFRP2 ETV1 NDRG2 HHIP CELF2 MMP2	1.00e-05	195	112	6	01a750d660993017af00736215cbcff2de5909c1
ToppCell	E17.5-Mesenchymal\|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ETV1 NDRG2 HHIP CELF2 GUCY1A1 MMP2	1.03e-05	196	112	6	b4ee991445b612506372b9361ebfe72cb59b811e
ToppCell	proximal-Hematologic-Interstitial_Macrophage\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CLEC5A DENND1A TLR4 MMP9 TRIM36 NLRP8	1.03e-05	196	112	6	b6a858c43fef42cd724d56c8283e954bcb546106
ToppCell	(05)_Secretory-(0)_Reference\|(05)_Secretory / shred by cell type by condition	ATRN NDRG2 IGF2BP1 LTF NPAS4 SORD	1.03e-05	196	112	6	7cb79cf122852c971f2d6e8d1e2b26eade891e83
ToppCell	proximal-3-Hematologic-Interstitial_Macrophage\|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CLEC5A DENND1A TLR4 MMP9 TRIM36 NLRP8	1.03e-05	196	112	6	d8c9cb86233470c3044865ad05ea202e294d80bf
ToppCell	proximal-Hematologic-Interstitial_Macrophage-3\|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)	CLEC5A DENND1A TLR4 MMP9 TRIM36 NLRP8	1.03e-05	196	112	6	9d4d8ffe9d30de7d1dc33d261bc2aaf4189ad86c
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP2 NDRG2 HHIP GUCY1A1 PAM MMP2	1.06e-05	197	112	6	e132f4b9deef6a565262c0aa0863cafe28f248e6
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP2 NDRG2 HHIP CELF2 PAM MMP2	1.09e-05	198	112	6	63f7d25201613bd3404c28fb936954190bca91d3
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP2 NDRG2 HHIP CELF2 PAM MMP2	1.09e-05	198	112	6	d1e1bdd36c84e1bac21ba137f018defe98456a8c
ToppCell	E18.5-Mesenchymal\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ETV1 NDRG2 HHIP CELF2 GUCY1A1 MMP2	1.09e-05	198	112	6	a16aa41eab2e297e56de43c22c355df0f79315da
ToppCell	Skin-Mesangial\|Skin / Skin and Kidney Cells in Lupus Nephritis Patients.	ATAD5 TECTA MROH8 SEMA6D GPR150 GUCY1A1	1.13e-05	199	112	6	bcb78838a91cc7828680fb413fbacdb091c5fac0
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	SFRP2 ZNF521 ABCA10 LEPR CELF2 MMP2	1.16e-05	200	112	6	b4ccffdd79526c85e5273d27b668dbddcddba1ee
ToppCell	Substantia_nigra-Neuronal-Excitatory\|Substantia_nigra / BrainAtlas - Mouse McCarroll V32	ESM1 PTK2B ESYT3 LRFN2 GPR150	1.22e-05	118	112	5	9f1d744f46d79ff2ab7f168f54fdbd9f4640dddd
ToppCell	droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ZNF618 NDRG2 LHCGR GUCY1A1 KCNMB1	3.19e-05	144	112	5	121853910eeea1ea0642b3cc99f9200015480368
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MBOAT1 RBPJL DCT HHIP TMEM63A	3.64e-05	148	112	5	44128692824ca419fface0af41099c17135933ce
ToppCell	primary_visual_cortex-Non-neuronal-oligodendrocyte-Oligo\|primary_visual_cortex / Per Region, Lineage, Cell class, Cell type, Cell subtype	MBOAT1 RBPJL DCT HHIP TMEM63A	3.64e-05	148	112	5	d60f93311cfa718d026a0dbf61771bbbcbb79146
ToppCell	367C-Lymphocytic-NK_cells-NK_cell_D2\|Lymphocytic / Donor, Lineage, Cell class and subclass (all cells)	CCNJL ABCA10 IGF2BP1 CCL5 KLRD1	4.00e-05	151	112	5	09405a450af3ea246d9685a6d3137dfaec80e9bf
ToppCell	renal_cortex_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	CCR10 ZNF618 PPEF1 CELF2 TMEM117	4.13e-05	152	112	5	655d47efe0608d729801f1f01668e84c1bc0675f
ToppCell	droplet-Heart-nan-24m-Hematologic-nan\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MBOAT1 SPINT1 WDFY4 ESYT3 KLRD1	5.43e-05	161	112	5	7e60001637ef0f6fc67ef8a36ab80ebb25b0b0ab
ToppCell	droplet-Limb_Muscle-nan-18m-Myeloid-chondrocyte-like\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP2 SPINT1 CLEC5A ZNF521 CEMIP	5.59e-05	162	112	5	71d7849108a1b59beff40e46000172c45a2f5439
ToppCell	COVID-CD8-exh_CD4\|COVID / Condition, Cell_class and T cell subcluster	ESM1 LEPR RLF CCL5 TOP2A	6.28e-05	166	112	5	4ca8c91b03d08489f244898cf9423b9d10348bc8
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SFRP2 ZNF618 CEMIP LRFN2 TMEM117	6.46e-05	167	112	5	743df5908c1ceb43b34b240d9f9649f30f4142fa
ToppCell	facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell\|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype	SFRP2 ZNF618 CEMIP LRFN2 TMEM117	6.46e-05	167	112	5	1adb566f98af0109c8cc6e36033b89651e2c75e7
ToppCell	droplet-Kidney-nan-18m-Epithelial-Pecam____kidney_capillary_endothelial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CCNJL SFRP2 GUCY1A1 HECTD2 MMP2	6.83e-05	169	112	5	87116c33c5ca8cb1862e103e5607b1df4d264569
ToppCell	Tracheal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD11d\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	MTA2 LRFN2 CCL5 KLRD1	6.91e-05	87	112	4	f92e08c2d1c2f216063ecfd42b06652e558c1a89
ToppCell	3'-Child09-12-SmallIntestine-Hematopoietic-T_cells-TRGV4_gdT\|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	MTA2 MROH8 CCL5 GOLGA7B KLRD1	7.03e-05	170	112	5	65c7ed586e7615203a59999549892ed466a89502
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC2\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPINT1 CLEC5A WDFY4 KLRD1 TOP2A	7.23e-05	171	112	5	e01bef6d814c0b7bd015c71e20a194e2dec68377
ToppCell	PND28-Immune-Immune_Myeloid-DC-cDC2-cDC2_mature\|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SPINT1 CLEC5A WDFY4 KLRD1 TOP2A	7.23e-05	171	112	5	41f858831a2919a2cacea62f51c2b723eb87b9c4
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue-3\|TCGA-Breast / Sample_Type by Project: Shred V9	GPAM ABCA10 LEPR ADRA1A ACSM5	7.84e-05	174	112	5	7f8f5fafae08676d2b90cab9802c3c9320f1370e
ToppCell	TCGA-Breast-Solid_Tissue_Normal\|TCGA-Breast / Sample_Type by Project: Shred V9	GPAM ABCA10 LEPR ADRA1A ACSM5	7.84e-05	174	112	5	e2f240d60bffbe8e6d60f0bb405b231bd3c96875
ToppCell	E16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP2 ETV1 HHIP KCNMB1 MMP2	7.84e-05	174	112	5	c529f3674b784f872f4387ffdeb46aecb619976b
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	GPAM ABCA10 LEPR ADRA1A ACSM5	7.84e-05	174	112	5	0f3ec0d0d4344e10c9b48adc9174123f6402dc51
ToppCell	10x3'2.3-week_17-19-Myeloid_DC-DC-DC2\|week_17-19 / cell types per 3 fetal stages;per 3',per 5'	NBEAL1 NDRG2 ADGB LHCGR KCNMB1	7.84e-05	174	112	5	60ee7c6f1b6972e6647a16848087cc60e0060bbe
ToppCell	TCGA-Breast-Solid_Tissue_Normal-Breast_normal_tissue\|TCGA-Breast / Sample_Type by Project: Shred V9	GPAM ABCA10 LEPR ADRA1A ACSM5	7.84e-05	174	112	5	1aadbf2642b6d1320ceabd92e6ff59e11f16c315
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RBPJL DCT CCL5 MMP2	7.88e-05	90	112	4	a0baaf2b3cf07d457f0d242fc213689cba6fd449
ToppCell	Hippocampus-Macroglia-POLYDENDROCYTE-P3-Tnr\|Hippocampus / BrainAtlas - Mouse McCarroll V32	RBPJL DCT CCL5 MMP2	7.88e-05	90	112	4	ab4b08c6ac8695b38f841c0ecf2bb2c032111d04
ToppCell	10x_3'_v2v3-Non-neoplastic-Lymphoid-CD4/CD8-CD8_cytotoxic-D\|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	MBOAT1 ESM1 DENND1A PTK2B MEIOC	8.06e-05	175	112	5	a3f8c54c77bce9b035a4835945ab341909be4946
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	MBOAT1 G2E3 LEPR GUCY1A1 TOP2A	8.06e-05	175	112	5	3e56695a9db97cb1d3503425c48eb79bbf99213e
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-T_cells-NK_T_cell\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CCNJL ESM1 CELF2 CCL5 KLRD1	8.28e-05	176	112	5	dbc4f64cd39b229f2355ca1d0215cc7f6a767dce
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TDRD9 ETV1 LHCGR PAM NPAS4	8.50e-05	177	112	5	1dc69c661e70e7e22bd9d7cf953eb638da9fd43c
ToppCell	droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_A_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TDRD9 ETV1 LHCGR PAM NPAS4	8.50e-05	177	112	5	426a9845df7fd13b02e744532c336c60bc4d4a22
ToppCell	E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1-AT1_prolif\|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ZNF521 IDE SAMD15 IGF2BP1 TMEM117	9.44e-05	181	112	5	f6629fa71bb94405f523f63a9264cacf6d15c5f4
ToppCell	3'-Child04-06-SmallIntestine-Mesenchymal-fibroblastic-Stromal_3_(C7+)\|Child04-06 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	SFRP2 NDRG2 GUCY1A1 PAM MMP2	9.44e-05	181	112	5	e1ae9ada60ec89e7a7cde9c231c1a099ed2ffecc
ToppCell	PBMC_fresh-frozen-Mild-Moderate_progression_d02_child-Lymphocytic-Lymphocytic_B-Plasma_cell-B_c06-MKI67\|Mild-Moderate_progression_d02_child / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF567 LEPR ESYT3 RECQL5 TOP2A	9.44e-05	181	112	5	c18e5a3f5d99043fa3cb33e2ac33fa98cd15d3db
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	LAMB4 ZNF521 ESM1 SEMA6D MMP2	9.69e-05	182	112	5	d7cce5dd7046f06bf40f00c9dbfa610722b03333
ToppCell	E18.5-samps-Mesenchymal-Myofibroblast\|E18.5-samps / Age Group, Lineage, Cell class and subclass	SFRP2 ETV1 ZNF521 HHIP MMP2	9.94e-05	183	112	5	de08f9ea02b7244d5a8788064631d10f06565337
ToppCell	droplet-Kidney-KIDNEY-30m-Epithelial-Stroma____kidney_mesangial_cell\|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP2 ADGRB1 HOXC11 GUCY1A1 KCNMB1	9.94e-05	183	112	5	8de4b616a06be03e1cb6ae6a9ce6bf06485629d3
ToppCell	facs-Lung-EPCAM-24m\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPINT1 WDFY4 CELF2 WDR89 KLRD1	9.94e-05	183	112	5	b082fb7afab13106ddeb764fab4c32c485123f74
ToppCell	P28-Mesenchymal-mesenchymal_fibroblast-alveolar_fibroblast_Wnt2-pa\|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	ETV1 NDRG2 ADRA1A CELF2 MMP2	1.02e-04	184	112	5	924400f47e6b2cdf7b0d538df75857935cf0209b
ToppCell	10x5'-blood-Myeloid_Dendritic-DC1\|blood / Manually curated celltypes from each tissue	SPINT1 ZNF521 NDRG2 WDFY4 KCNMB1	1.02e-04	184	112	5	09fa465d1852b9b7e0405c27d4e5de276c9ba871
ToppCell	PND10-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_G2M\|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP2 MBOAT1 PPEF1 GUCY1A1 TOP2A	1.02e-04	184	112	5	d1e0e3b0eed2db8a5b7e3d6f81294667e4ba64e5
ToppCell	droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5+_undifferentiated_cell\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	HSPD1 GPR150 GUCY1A1 CC2D2A SORD	1.02e-04	184	112	5	e7b9c69fc77040c5191ad8089697051e2589c30e
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRN ATAD5 CLEC5A TSHR NDRG2	1.05e-04	185	112	5	53854a9ec87c24c360541c83d86d8fafb303ad58
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocyte_monocyte_progenitor_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ATRN ATAD5 CLEC5A TSHR NDRG2	1.05e-04	185	112	5	a61fc7a3700a1efcf640bef7680c0443ee148a46
ToppCell	Adult-Mesenchymal-matrix_fibroblast_2_cell-D231\|Adult / Lineage, Cell type, age group and donor	SFRP2 ZNF521 ABCA10 LEPR MMP2	1.05e-04	185	112	5	fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804
ToppCell	COVID-19-Fibroblasts-Adventitial_FB\|COVID-19 / group, cell type (main and fine annotations)	SFRP2 ABCA10 LEPR CEMIP MMP2	1.05e-04	185	112	5	a5aebf2b9b05b550d021272731d68af9a6b1229d
ToppCell	droplet-Limb_Muscle-nan-24m-Macroglial-nan\|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRB1 ETV1 ADGB LHCGR PSAPL1	1.07e-04	186	112	5	adba5647a2feaba8e361dc1020d2f2dc4ce36b16
ToppCell	E16.5-samps-Mesenchymal-Myofibroblast\|E16.5-samps / Age Group, Lineage, Cell class and subclass	SFRP2 ETV1 HHIP SEMA6D MMP2	1.07e-04	186	112	5	e044b3428b7eacfdc72d0f57cdabaa1de04c74cd
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADGRB1 PTK2B WDR89 CCL5 KLRD1	1.07e-04	186	112	5	7278a1a1bf9bb27aeb03852134defb31b62f30d6
ToppCell	tumor_Lymph_Node_/_Brain-Endothelial_cells-Tumor_ECs\|tumor_Lymph_Node_/_Brain / Location, Cell class and cell subclass	LAMB4 ZNF521 ESM1 SEMA6D MMP2	1.10e-04	187	112	5	be5f8c5802b0fa8cc1e274fdf06b13eb8ceb8ad4
ToppCell	E16.5-samps-Mesenchymal\|E16.5-samps / Age Group, Lineage, Cell class and subclass	ETV1 HHIP CELF2 GUCY1A1 MMP2	1.13e-04	188	112	5	3f0f662be684e3a4c6652e636cc135a39a1d2790
ToppCell	Monocytes-Tissue-resident_macrophages\|World / Immune cells in Kidney/Urine in Lupus Nephritis	ZNF618 CLEC5A NDRG2 KCNMB1 MMP2	1.19e-04	190	112	5	07215e8f292cb54c670037aaf28393cddbe5548c
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP2 NDRG2 GUCY1A1 KCNMB1 PAM	1.19e-04	190	112	5	7df63e5e0dd395676f4fc18cad0d8b2428390943
ToppCell	PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-VSMC-VSMC_mature\|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	SFRP2 NDRG2 GUCY1A1 KCNMB1 PAM	1.19e-04	190	112	5	140aca04c044cd7a93f81ff1631b00b5216d2cb1
ToppCell	PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_proliferating_SM_(20)\|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung	ATAD5 HHIP SEMA6D KCNMB1 TOP2A	1.19e-04	190	112	5	e83fa8b711aa79a1767818474f1c193b674b1c31
ToppCell	renal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Monocytic-Monocyte-derived_Cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	BMP2K CLEC5A WDFY4 CELF2 KCNMB1	1.28e-04	193	112	5	3e3d7cb3e7242ec9c9677e07e303835649852b52
ToppCell	E15.5-Mesenchymal-myocytic_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SFRP2 NDRG2 HHIP KCNMB1 MMP2	1.28e-04	193	112	5	3316d6a39abb6a518d45b846254325fc7a8b2035
ToppCell	E15.5-Mesenchymal-mesenchymal_fibroblast\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SFRP2 ETV1 CELF2 GUCY1A1 MMP2	1.28e-04	193	112	5	b637e1c47a98009e7d19a6daac78f888fd12748f
ToppCell	E15.5-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SFRP2 NDRG2 HHIP KCNMB1 MMP2	1.28e-04	193	112	5	e787e618f6e8a1e22be366ce606bf78831b60a90
ToppCell	facs-Tongue-nan-3m-Epithelial-keratinocyte\|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SPINT1 BMP2K IDE NDRG2 PSAPL1	1.28e-04	193	112	5	33437fdb417d78463caee14a9f0e094da1733829
ToppCell	droplet-Heart-nan-18m-Mesenchymal\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP2 NDRG2 CELF2 PAM MMP2	1.31e-04	194	112	5	20a0439fa02c5f8107612e34c7ab54120b9b8573
ToppCell	P15-Mesenchymal-myocytic_cell-aortic_smooth_muscle_cell\|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase	SLC25A33 HHIP CELF2 PAM MMP2	1.31e-04	194	112	5	5f04d21c4e2d36e74b6c5889aa97fd98f75a0973
ToppCell	TCGA-Head_and_Esophagus-Primary_Tumor-Head_and_Neck_Carcinoma-Squamous_Cell_Carcinoma-8\|TCGA-Head_and_Esophagus / Sample_Type by Project: Shred V9	MYH3 SFRP2 ZNF521 PPEF1 MMP2	1.31e-04	194	112	5	55b97095a7a17a312c616703d291738a0f806339
ToppCell	facs-Bladder-nan-3m-Epithelial-bladder_mesenchymal_cell_(Car3+)\|Bladder / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation	SFRP2 LEPR HHIP PAM MMP2	1.34e-04	195	112	5	18b01ab63ee1deae3cf29669d66fff9ca4efc5c4
ToppCell	E18.5-Mesenchymal-Mesenchymal_myocytic\|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif	ETV1 NDRG2 HHIP GUCY1A1 MMP2	1.34e-04	195	112	5	2eed0332e338d6f0dbcb399d9d36c4611d491b0a
Computational	Metal ion (zinc) binding.	PAM LTF MMP2 MMP9 SORD	3.05e-06	45	55	5	MODULE_280
Drug	norfenefrine	PTK2B ADRA1A MMP2 MMP9	1.96e-06	19	111	4	CID000004538
Drug	Alpatp	LTF MMP2 MMP9	2.23e-06	6	111	3	CID000131722
Drug	Razoxane	MYH3 LEPR MMP2 MMP9 TOP2A	3.64e-06	48	111	5	ctd:D011929
Drug	Piperidolate hydrochloride [129-77-1]; Up 200; 11.2uM; MCF7; HT_HG-U133A	LAMB4 ZZEF1 TRAK1 SEMA6D NPY4R BTD RECQL5 TMEM63A	5.62e-06	197	111	8	3551_UP
Drug	2',3'-dideoxy-3'-fluoro-5-ethyluridine	LTF MMP2 MMP9	9.27e-06	9	111	3	CID000451414
Drug	Silicon	HSPD1 MMP2 MMP9	1.32e-05	10	111	3	ctd:D012825
Drug	ND 322	MMP2 MMP9	2.36e-05	2	111	2	ctd:C568509
Drug	AC1Q62J9	MMP2 MMP9	2.36e-05	2	111	2	CID000475273
Drug	Ro 28-2653	MMP2 MMP9	2.36e-05	2	111	2	ctd:C453902
Drug	S 3304	MMP2 MMP9	2.36e-05	2	111	2	ctd:C503948
Drug	pipoxolan	MMP2 MMP9	2.36e-05	2	111	2	ctd:C000121
Drug	matlystatin B	MMP2 MMP9	2.36e-05	2	111	2	CID000132321
Drug	betulinic acid	TLR4 MMP2 MMP9 TOP2A	2.49e-05	35	111	4	ctd:C002070
Drug	acetyl-11-ketoboswellic acid	MMP2 MMP9 TOP2A	3.11e-05	13	111	3	ctd:C094432
Drug	CP-320650-01 [172079-28-6]; Up 200; 10uM; MCF7; HT_HG-U133A	CYP2C8 ETV1 LEPR ADRA1A NPY4R CCL5 TRIM36	4.86e-05	195	111	7	4379_UP
Drug	(1)-Nipecotic acid [498-95-3]; Up 200; 31uM; MCF7; HT_HG-U133A	MTA2 TSHR ZZEF1 LEPR SEMA6D RECQL5 CDH10	5.02e-05	196	111	7	5999_UP
Drug	Methimazole [60-56-0]; Up 200; 35uM; HL60; HT_HG-U133A	MTA2 NDRG2 PTK2B RECQL5 TRIM36 SEC23B TMEM63A	5.02e-05	196	111	7	2570_UP
Drug	Glucose	HSPD1 MTA2 SLC25A33 ZNF521 IDE NDRG2 DENND1A LEPR IGF2BP1 ADRA1A TLR4 KCNMB1 WDR89 CCL5 MMP2 MMP9 TRIM36 TOP2A SORD	5.36e-05	1420	111	19	ctd:D005947
Drug	Trichostatin A, from Streptomyces sp.; Up 200; 0.1uM; MCF7; HT_HG-U133A	LAMB4 CYP2C8 NDRG2 KCNMB1 CCL5 TRIM36 TMEM63A	5.53e-05	199	111	7	4348_UP
Drug	Eucatropine hydrochloride [536-93-6]; Up 200; 12.2uM; PC3; HT_HG-U133A	ETV1 TSHR NDRG2 LEPR CEMIP MAP2K7 KLRD1	5.53e-05	199	111	7	3759_UP
Drug	Chlormezanone [80-77-3]; Up 200; 14.6uM; MCF7; HT_HG-U133A	ETV1 ESM1 NDRG2 ADRA1A NPY4R GUCY1A1 TRIM36	5.53e-05	199	111	7	5697_UP
Drug	Sulfamerazine [127-79-7]; Down 200; 15.2uM; MCF7; HT_HG-U133A	NDRG2 DENND1A LEPR TRAK1 CELF2 NPY4R TMEM63A	5.53e-05	199	111	7	3616_DN
Drug	SU 1498	MMP2 MMP9	7.04e-05	3	111	2	ctd:C483044
Drug	Captopril	MMP2 MMP9	7.04e-05	3	111	2	DB01197
Drug	zosterin	MMP2 MMP9	7.04e-05	3	111	2	ctd:C070927
Drug	AMD 6221	MMP2 MMP9	7.04e-05	3	111	2	ctd:C453459
Drug	SB 3CT compound	MMP2 MMP9	7.04e-05	3	111	2	ctd:C429533
Drug	delta-(3,4-dihydroxyphenyl)-gamma-valerolactone	MMP2 MMP9	7.04e-05	3	111	2	CID000152432
Drug	4-(4-(4-fluorophenoxy)benzenesulfonylamino)tetrahydropyran-4-carboxylic acid hydroxyamide	MMP2 MMP9	7.04e-05	3	111	2	ctd:C532757
Drug	alpha-benzoylamino-1,4-naphthoquinone	MMP2 MMP9	7.04e-05	3	111	2	ctd:C109682
Drug	CP-471,358	MMP2 MMP9	7.04e-05	3	111	2	ctd:C495612
Drug	AC1L916B	CCL5 MMP2 MMP9	7.30e-05	17	111	3	CID000436250
Drug	zinc protoporphyrin	GUCY1A1 TLR4 MMP2 MMP9 ASF1A SEC23B	7.86e-05	145	111	6	ctd:C017803
Disease	Diabetic Neuralgia	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0751074
Disease	Diabetic Neuropathies	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0011882
Disease	Asymmetric Diabetic Proximal Motor Neuropathy	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0271674
Disease	Symmetric Diabetic Proximal Motor Neuropathy	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0271673
Disease	Diabetic Mononeuropathy	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0271678
Disease	Diabetic Autonomic Neuropathy	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0271686
Disease	Diabetic Amyotrophy	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0271685
Disease	Diabetic Polyneuropathies	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0271680
Disease	Diabetic Asymmetric Polyneuropathy	LEPR TLR4 MMP2 MMP9	1.84e-07	14	111	4	C0393835
Disease	Bone neoplasms	BAP1 MMP2 MMP9	2.86e-06	8	111	3	C0005967
Disease	Malignant Bone Neoplasm	BAP1 MMP2 MMP9	2.86e-06	8	111	3	C0279530
Disease	arteriosclerosis (is_implicated_in)	HSPD1 TLR4 MMP2 MMP9	5.52e-06	31	111	4	DOID:2349 (is_implicated_in)
Disease	cholesteatoma (is_marker_for)	TLR4 MMP2 MMP9	6.10e-06	10	111	3	DOID:869 (is_marker_for)
Disease	hypertension (is_implicated_in)	LEPR PTK2B ADRA1A KCNMB1 MMP2 MMP9	6.69e-06	121	111	6	DOID:10763 (is_implicated_in)
Disease	Hypertensive disease	LEPR GUCY1A1 TLR4 KCNMB1 LTF MMP2 MMP9	7.93e-06	190	111	7	C0020538
Disease	pyoderma gangrenosum (is_marker_for)	MMP2 MMP9	1.40e-05	2	111	2	DOID:8553 (is_marker_for)
Disease	Sweet syndrome (is_marker_for)	MMP2 MMP9	1.40e-05	2	111	2	DOID:0080746 (is_marker_for)
Disease	cholesteatoma of middle ear (is_marker_for)	TLR4 MMP2 MMP9	2.80e-05	16	111	3	DOID:10964 (is_marker_for)
Disease	temporal arteritis (is_implicated_in)	TLR4 MMP2 MMP9	2.80e-05	16	111	3	DOID:13375 (is_implicated_in)
Disease	endometriosis (biomarker_via_orthology)	CCL5 MMP2 MMP9	2.80e-05	16	111	3	DOID:289 (biomarker_via_orthology)
Disease	Necrotizing Enterocolitis	TLR4 LTF SORD	3.39e-05	17	111	3	C0520459
Disease	heart valve disease (is_marker_for)	MMP2 MMP9	4.20e-05	3	111	2	DOID:4079 (is_marker_for)
Disease	pulmonary embolism (implicated_via_orthology)	MMP2 MMP9	4.20e-05	3	111	2	DOID:9477 (implicated_via_orthology)
Disease	Stable angina	TLR4 MMP9	4.20e-05	3	111	2	C0340288
Disease	Sturge-Weber syndrome (is_marker_for)	MMP2 MMP9	4.20e-05	3	111	2	DOID:0111563 (is_marker_for)
Disease	Alzheimer's disease (is_marker_for)	HSPD1 SPINT1 IDE BPTF CCL5 MMP2 MMP9	5.51e-05	257	111	7	DOID:10652 (is_marker_for)
Disease	Streptozotocin Diabetes	GPAM LEPR ADRA1A MMP2 MMP9	5.64e-05	108	111	5	C0038433
Disease	Diabetes Mellitus, Experimental	GPAM LEPR ADRA1A MMP2 MMP9	5.64e-05	108	111	5	C0011853
Disease	Alloxan Diabetes	GPAM LEPR ADRA1A MMP2 MMP9	5.64e-05	108	111	5	C0002152
Disease	carotid artery disease (is_implicated_in)	TLR4 MMP2 MMP9	7.57e-05	22	111	3	DOID:3407 (is_implicated_in)
Disease	arabitol measurement, xylitol measurement	SAMD15 SORD	8.37e-05	4	111	2	EFO_0800148, EFO_0801067
Disease	Lupus Nephritis	MMP2 MMP9	8.37e-05	4	111	2	C0024143
Disease	thoracic aortic aneurysm (biomarker_via_orthology)	MMP2 MMP9	8.37e-05	4	111	2	DOID:14004 (biomarker_via_orthology)
Disease	stomach carcinoma (biomarker_via_orthology)	MMP2 MMP9	8.37e-05	4	111	2	DOID:5517 (biomarker_via_orthology)
Disease	chronic obstructive pulmonary disease (is_implicated_in)	LEPR HHIP TLR4 MMP9	9.52e-05	63	111	4	DOID:3083 (is_implicated_in)
Disease	non-alcoholic fatty liver disease (biomarker_via_orthology)	GPAM IDE TLR4 CCL5	1.08e-04	65	111	4	DOID:0080208 (biomarker_via_orthology)
Disease	Liver carcinoma	CYP2C8 ESM1 HHIP IGF2BP1 ADRA1A TLR4 MMP2 MMP9 TOP2A	1.30e-04	507	111	9	C2239176
Disease	renal hypertension (implicated_via_orthology)	MMP2 MMP9	1.39e-04	5	111	2	DOID:1073 (implicated_via_orthology)
Disease	Aortic Rupture	MMP2 MMP9	1.39e-04	5	111	2	C0003496
Disease	adrenoleukodystrophy (is_marker_for)	MMP2 MMP9	1.39e-04	5	111	2	DOID:10588 (is_marker_for)
Disease	Aortic Aneurysm, Ruptured	MMP2 MMP9	1.39e-04	5	111	2	C0741160
Disease	primary biliary cholangitis (biomarker_via_orthology)	HHIP MMP2 MMP9	1.58e-04	28	111	3	DOID:12236 (biomarker_via_orthology)
Disease	amyotrophic lateral sclerosis (is_marker_for)	BPTF MMP2 MMP9	1.76e-04	29	111	3	DOID:332 (is_marker_for)
Disease	Malignant neoplasm of breast	SFRP2 TECTA LEPR BAP1 LHCGR ADRA1A MMP2 MMP9 ZBTB3 MAP2K7 CDH10 TOP2A NLRP8	2.03e-04	1074	111	13	C0006142
Disease	pulmonary emphysema (biomarker_via_orthology)	MMP2 MMP9	2.08e-04	6	111	2	DOID:9675 (biomarker_via_orthology)
Disease	Aortic Diseases	MMP2 MMP9	2.08e-04	6	111	2	C0003493
Disease	Neointima Formation	MMP2 MMP9	2.08e-04	6	111	2	C2936381
Disease	Neointima	MMP2 MMP9	2.08e-04	6	111	2	C2936380
Disease	hypertension (biomarker_via_orthology)	HSPD1 PTK2B ADRA1A KCNMB1 MMP2 MMP9	2.24e-04	227	111	6	DOID:10763 (biomarker_via_orthology)
Disease	Cholestasis, Extrahepatic	TLR4 MMP2 MMP9	2.37e-04	32	111	3	C0005398
Disease	Acute Coronary Syndrome	HSPD1 TLR4 MMP9	2.60e-04	33	111	3	C0948089
Disease	Behcet's disease (is_marker_for)	TLR4 MMP2 MMP9	2.60e-04	33	111	3	DOID:13241 (is_marker_for)
Disease	Colonic Neoplasms	NDRG2 BAP1 GUCY1A1 LTF MMP9	2.81e-04	152	111	5	C0009375
Disease	liver cirrhosis (biomarker_via_orthology)	SPINT1 TLR4 MMP2	2.85e-04	34	111	3	DOID:5082 (biomarker_via_orthology)
Disease	Aortic Aneurysm, Thoracic	MMP2 MMP9	2.91e-04	7	111	2	C0162872
Disease	Aortic Aneurysm, Thoracoabdominal	MMP2 MMP9	2.91e-04	7	111	2	C0340630
Disease	cardiomyopathy (is_marker_for)	MMP2 MMP9	2.91e-04	7	111	2	DOID:0050700 (is_marker_for)
Disease	Malignant tumor of colon	NDRG2 BAP1 GUCY1A1 LTF MMP9	3.45e-04	159	111	5	C0007102
Disease	physical activity	MBOAT1 ZNF521 TLR4 NLRP8	3.47e-04	88	111	4	EFO_0003940
Disease	myocardial infarction (biomarker_via_orthology)	HSPD1 SFRP2 CCL5 MMP2 MMP9	3.55e-04	160	111	5	DOID:5844 (biomarker_via_orthology)
Disease	ductal carcinoma in situ (is_marker_for)	MMP2 MMP9 TOP2A	4.29e-04	39	111	3	DOID:0060074 (is_marker_for)
Disease	Marfan Syndrome, Type I	MMP2 MMP9	4.96e-04	9	111	2	C4721845
Disease	abdominal aortic aneurysm (implicated_via_orthology)	MMP2 MMP9	4.96e-04	9	111	2	DOID:7693 (implicated_via_orthology)
Disease	chronic obstructive pulmonary disease (is_marker_for)	LEPR TLR4 CCL5 MMP9	5.02e-04	97	111	4	DOID:3083 (is_marker_for)
Disease	coronary artery disease (is_implicated_in)	HSPD1 LEPR TLR4 MMP9	5.63e-04	100	111	4	DOID:3393 (is_implicated_in)
Disease	glioblastoma (is_marker_for)	ADGRB1 MMP2 MMP9	6.13e-04	44	111	3	DOID:3068 (is_marker_for)
Disease	cutaneous leishmaniasis (is_marker_for)	TLR4 MMP2	6.19e-04	10	111	2	DOID:9111 (is_marker_for)
Disease	abdominal aortic aneurysm (is_marker_for)	MMP2 MMP9	6.19e-04	10	111	2	DOID:7693 (is_marker_for)
Disease	pleural tuberculosis (is_marker_for)	TLR4 MMP9	6.19e-04	10	111	2	DOID:106 (is_marker_for)
Disease	Colorectal Neoplasms	SFRP2 ETV1 ABCA10 HHIP TLR4 MMP2	6.44e-04	277	111	6	C0009404
Disease	pneumococcal bacteremia	LAMB4 ETV1	7.54e-04	11	111	2	EFO_1001925
Disease	Premature Birth	LTF MMP9	7.54e-04	11	111	2	C0151526
Disease	Marfan Syndrome	MMP2 MMP9	7.54e-04	11	111	2	C0024796
Disease	obstructive sleep apnea (is_implicated_in)	LEPR MMP9	7.54e-04	11	111	2	DOID:0050848 (is_implicated_in)
Disease	multiple sclerosis (is_marker_for)	TLR4 CCL5 MMP9	8.42e-04	49	111	3	DOID:2377 (is_marker_for)
Disease	Fibrosis	LEPR TLR4 MAP2K7	8.93e-04	50	111	3	C0016059
Disease	diabetic retinopathy (is_implicated_in)	TLR4 MMP2 MMP9	8.93e-04	50	111	3	DOID:8947 (is_implicated_in)
Disease	Cirrhosis	LEPR TLR4 MAP2K7	8.93e-04	50	111	3	C1623038
Disease	Centriacinar Emphysema	MMP2 MMP9	9.03e-04	12	111	2	C0221227
Disease	Panacinar Emphysema	MMP2 MMP9	9.03e-04	12	111	2	C0264393
Disease	Focal Emphysema	MMP2 MMP9	9.03e-04	12	111	2	C2350878
Disease	intracranial aneurysm (is_implicated_in)	MMP2 MMP9	9.03e-04	12	111	2	DOID:10941 (is_implicated_in)
Disease	focal segmental glomerulosclerosis (biomarker_via_orthology)	MMP2 MMP9	9.03e-04	12	111	2	DOID:1312 (biomarker_via_orthology)
Disease	non-alcoholic steatohepatitis	NDRG2 LEPR	9.03e-04	12	111	2	EFO_1001249
Disease	lung disease (implicated_via_orthology)	TLR4 MMP9	1.06e-03	13	111	2	DOID:850 (implicated_via_orthology)
Disease	cholangiocarcinoma (biomarker_via_orthology)	MMP2 MMP9	1.06e-03	13	111	2	DOID:4947 (biomarker_via_orthology)
Disease	intracranial aneurysm (biomarker_via_orthology)	MMP2 MMP9	1.06e-03	13	111	2	DOID:10941 (biomarker_via_orthology)
Disease	skin melanoma (is_marker_for)	MMP2 MMP9	1.06e-03	13	111	2	DOID:8923 (is_marker_for)
Disease	diabetic retinopathy (is_marker_for)	CCL5 MMP2 MMP9	1.12e-03	54	111	3	DOID:8947 (is_marker_for)
Disease	alcohol use disorder (biomarker_via_orthology)	MMP2 MMP9	1.24e-03	14	111	2	DOID:1574 (biomarker_via_orthology)
Disease	Kawasaki disease (is_marker_for)	TLR4 MMP9	1.24e-03	14	111	2	DOID:13378 (is_marker_for)
Disease	intracranial aneurysm (is_marker_for)	MMP2 MMP9	1.24e-03	14	111	2	DOID:10941 (is_marker_for)
Disease	diabetic neuropathy (implicated_via_orthology)	TLR4 SORD	1.24e-03	14	111	2	DOID:9743 (implicated_via_orthology)
Disease	Inflammation	TLR4 LTF MMP2 MMP9	1.37e-03	127	111	4	C0021368
Disease	pre-eclampsia (is_marker_for)	TLR4 MMP2 MMP9	1.38e-03	58	111	3	DOID:10591 (is_marker_for)
Disease	asthma (biomarker_via_orthology)	CARM1 CCL5 MMP9	1.44e-03	59	111	3	DOID:2841 (biomarker_via_orthology)
Disease	tea consumption measurement	ZNF618 ETV1 DENND1A LHCGR	1.46e-03	129	111	4	EFO_0010091
Disease	polycystic ovary syndrome	DENND1A LHCGR CDH10	1.52e-03	60	111	3	EFO_0000660
Disease	cystic fibrosis (is_marker_for)	HSPD1 TLR4 MMP9	1.67e-03	62	111	3	DOID:1485 (is_marker_for)
Disease	type 2 diabetes mellitus (is_marker_for)	TLR4 CCL5 MMP2 MMP9	1.77e-03	136	111	4	DOID:9352 (is_marker_for)

Protein segments in the cluster

Peptide	Gene	Start	Entry
NSQKPCFFNSYYIGK	ATAD5	1186	Q96QE3
RTFTFTKLYFGQKCP	ESYT3	156	A0FGR9
NLSKCFGFVSYDNPV	CELF2	461	O95319
CYKADVQAFSRAFQP	CCR10	31	P46092
IGFCPQFNFQFDFLT	ABCA10	471	Q8WWZ4
PSSYCLNFQKSEFKF	ADGB	651	Q8N7X0
EPCATLVQGKFFGYF	ADGRB1	41	O14514
SKCFGFVSYDNPVSA	CELF1	441	Q92879
YPCSSQEFKKAFQNV	ADRA1A	326	P35348
SPFYNPFQFEITFEC	ASF1A	16	Q9Y294
FYKFQPSVVAAACVG	CCNJL	246	Q8IV13
CKSFTNFSKVYGPVF	CYP2C8	51	P10632
QSKCQGPVYGFIFLF	BAP1	36	Q92560
YCNSRIVQFSPSGKF	PAM	651	P19021
FFNCYLDNPEKTAAS	ACSM5	431	Q6NUN0
PYFINTSKGQKCEFQ	HSPD1	226	P10809
NAAFCYKLPDNVTFE	SORD	136	Q00796
LYKLCFFTLPFGESQ	BMP2K	256	Q9NSY1
SPFYQCAEVLESFFV	BPTF	3011	Q12830
YDGPINIQNCTFRKF	CEMIP	881	Q8WUJ3
AELPGEANCTYFKFF	CACNG6	106	Q9BXT2
QKFFESLFACNICPY	ASTE1	61	Q2TB18
PFLFNGKEYNSCTDT	MMP2	236	P08253
FPFTFLGNKYESCTS	MMP2	351	P08253
TVEFVPFFYQCFQES	NBEAL1	191	Q6ZS30
VAQKSYGNEKRFFCP	RBPJL	76	Q9UBG7
CFFYSLVFDPVQKTL	MTA2	126	O94776
GSFCFKANPGTYKVQ	NOMO3	451	P69849
FKCPQSVKGRNDTFY	QRICH1	711	Q2TAL8
TDAFNPSLDCFFKYN	KBTBD3	466	Q8NAB2
KFQEQQVFYCFSAPR	KCNMB1	126	Q16558
LCVFPFTFLGKEYST	MMP9	346	P14780
SCANPFLYAIFTKTF	LHCGR	616	P22888
CVNPFIYGFLNTNFK	NPY4R	316	P50391
QEFFAALFYVLCFPQ	NLRP8	511	Q86W28
DYSDGTICQFQTKFP	GOLGA7B	26	Q2TAP0
GQFLVKSGYAFVDCP	IGF2BP1	31	Q9NZI8
KQCVDSNAYVASFPF	ATRN	956	O75882
FSFCQYPFVISVAAK	HECTD2	366	Q5U5R9
FATPNDFCSFYNILK	CARM1	111	Q86X55
ATGQFPYKNCKTDFE	MAP2K7	316	O14733
SACSQEQPFKFSYGE	ETV1	101	P50549
QSDGFYECIFQPIFL	LEPR	491	P48357
FFKEFCAFSQTLQPQ	PPP4R3B	336	Q5MIZ7
CVFLPDQGAFFVNYV	TMEM63A	546	O94886
FYNCPFRIAQVFEGF	MROH8	321	Q9H579
FSFPFCGTNKVNHFF	OR10A2	151	Q9H208
NPTKTYFAQEGCSFL	NPAS4	556	Q8IUM7
FESFFPYQVTERGCA	QTRT2	271	Q9H974
FFSKTLFNCLVYGPE	G2E3	466	Q7L622
GKFTCQVPGVYYFAV	C1QTNF5	141	Q9BXJ0
HFYGQFDTFCPLKNV	CC2D2A	1416	Q9P2K1
APQFAVFYDTFVCEN	CDH10	486	Q9Y6N8
CPKDGRYQFNTNVVF	BTD	186	P43251
FYTSGKCSNPAVVFV	CCL5	51	P13501
VLPQAFDRFFDNAYC	HOXC11	146	O43248
IAGPCNNFKDYIAFI	MBOAT1	196	Q6ZNC8
VLQTLTKFCFPFYVD	DENND1A	46	Q8TEH3
TGKCLKFPFFQYSVT	ESM1	126	Q9NQ30
FKYFAKDCATSFPNI	LAMB4	156	A4D0S4
KACLNFEFFSPFAYV	IDE	571	P14735
LKVCFYSNSFNPGKN	PTK2B	41	Q14289
QLGFPQYKECFITNF	SAMD15	556	Q9P1V8
PRFFQYQVTKATCFQ	PPEF1	446	O14829
PAVATQAKFTFYRCA	MROH5	1181	Q6ZUA9
LFQKYCQENPSAFSS	MEIOC	531	A2RUB1
FLFGQPDFSYKRSNC	SFRP2	26	Q96HF1
PVFSFLFDEKCGYNN	TRIM36	511	Q9NQ86
AVLCKNYLFQFFVPA	PSAPL1	221	Q6NUJ1
YQQCEFNFGAKPFKY	RSPRY1	471	Q96DX4
GENKCAFSSQEPYFS	LTF	196	P02788
LFQDFNPSKFLIYAC	TMEM185A	6	Q8NFB2
LFQDFNPSKFLIYTC	TMEM185B	6	Q9H7F4
SCKEFADYFAVPVQN	TDRD9	291	Q8NDG6
VGLNYKSCFQPLFQF	NDRG2	71	Q9UN36
TFEDFAVKFSPNCIY	OVCH1	461	Q7RTY7
QPNTYVGFKEFSRKC	HMGB4	31	Q8WW32
KNYGCVRVDFAQPFS	GPAM	391	Q9HCL2
ALNPFVYLFFQAGDC	GPR150	346	Q8NGU9
EAQNQPFDAKTYCFV	MYH3	26	P11055
DENYSLPTCKGFFNI	SEC23IP	806	Q9Y6Y8
IPGFLQTTADEFCFY	HHIP	156	Q96QV1
CQKFGQYNKEDPTSF	SEC23B	556	Q15437
CYSKAKEQFNGIFVP	SLC25A33	111	Q9BSK2
YFPQIFNKSNDGFTT	CLEC5A	26	Q9NY25
LQKYDCPFSGTSFVV	CLECL1	56	Q8IZS7
SFEFKCTSPPYDNFL	TRAK1	796	Q9UPV9
FKTPCFRANLFYDVQ	RECQL5	216	O94762
SKVNPTFFYKNCLFD	TECTA	1316	O75443
EVSFSNKPYFRGEFC	VPS51	471	Q9UID3
PAQSFGYNDCEKSFL	ZNF567	206	Q8N184
VQPFICTYCDKAFSF	ZFP1	181	Q6P2D0
QYTTFVKPAFEEFCL	UCK1	186	Q9HA47
FQKIGPKTGNYTCEF	ZNF618	246	Q5T7W0
FTFTLPAGQKECFYQ	TMED5	36	Q9Y3A6
PFFCELQGCKYEFVT	RLF	1126	Q13129
NFVCKFAPREGFINY	SPINT1	126	O43278
YDCTQCPQKFFFQTE	ZNF521	1286	Q96K83
FYLPEFLTNCNGVEF	WDFY4	2696	Q6ZS81
CVNPFIYGFLNTNFK	NPY4R2	316	P0DQD5
GTQPQFANCSVYDFF	DCT	171	P40126
LKPFNGEDYTCITFQ	TOP2A	206	P11388
SVFYFNFEACPLLEN	WDR93	606	Q6P2C0
QNFCGPYSELFKGFI	ZZEF1	1301	O43149
VVGNCFSFVTNKYPR	TMEM117	46	Q9H0C3
AYLVFAVCFVFTPNE	TMEM129	11	A0AVI4
KGYPSNIFISFDINC	WDR89	111	Q96FK6
RLNCSVPGDSFFYFD	SEMA6D	281	Q8NFY4
NFFSLDTFPYKCLNS	TLR4	531	O00206
SCANPFLYAIFTKAF	TSHR	671	P16473
VLASCSPFFQLFYKE	ZBTB3	91	Q9H5J0
FLDAYQQGTNSKPCF	GUCY1A1	656	Q02108
FPSFETFNTKNCIAY	KLRD1	141	Q13241
NIVGCAQFFTKADYP	LRFN2	506	Q9ULH4